Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS
· Delayed Price · Currency is USD
0.5230
+0.0031 (0.60%)
At close: Dec 5, 2025
Elite Pharmaceuticals Employees
Elite Pharmaceuticals had 68 employees as of March 31, 2025. The number of employees increased by 4 or 6.25% compared to the previous year.
Employees
68
Change (1Y)
4
Growth (1Y)
6.25%
Revenue / Employee
$1,807,255
Profits / Employee
$204,757
Market Cap
561.91M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Glass House Brands | 374 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 116 |
| Zomedica | 152 |
| Nuo Therapeutics | 9 |
Elite Pharmaceuticals News
- 17 days ago - ELTP Stock Declines Despite Solid Q2 Earnings and Revenue Performance - Nasdaq
- 18 days ago - Elite Pharmaceuticals Inc (ELTP) Q2 2026 Earnings Call Highlights: Surging Revenues and ... - GuruFocus
- 18 days ago - Q2 2026 Elite Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
- 18 days ago - Elite Pharmaceuticals, Inc. (ELTP) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 22 days ago - Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information - Newsfile Corp
- 26 days ago - Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 - Newsfile Corp
- 4 months ago - Elite Pharmaceuticals Inc (ELTP) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic ... - GuruFocus
- 4 months ago - Elite Pharmaceuticals GAAP EPS of -$0.01, revenue of $40.2M - Seeking Alpha